These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 37807729)

  • 1. Predictive Value of the Neutrophil-Lymphocyte Ratio for Tumor Regression Grade and Prognosis of Local Advanced Rectal Cancer Patients Undergoing Neoadjuvant Chemoradiotherapy.
    Li S; Wang D; Wei R; Yu G; Wang X; Jiang Z
    Technol Cancer Res Treat; 2023; 22():15330338231202611. PubMed ID: 37807729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive value of indirect bilirubin before neoadjuvant chemoradiotherapy in evaluating prognosis of local advanced rectal cancer patients.
    Li SF; Wei R; Yu GH; Jiang Z
    World J Gastrointest Oncol; 2022 Nov; 14(11):2224-2237. PubMed ID: 36438711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Prognostic Factors in Locally Advanced Rectal Cancer.
    Duque-Santana V; López-Campos F; Martin-Martin M; Valero M; Zafra-Martín J; Couñago F; Sancho S
    Oncology; 2023; 101(6):349-357. PubMed ID: 36273439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of mesorectal package area in patients with locally advanced rectal cancer following neoadjuvant chemoradiotherapy: A retrospective cohort study.
    Guan B; Huang X; Xia H; Guan G; Xu B
    Front Oncol; 2022; 12():941786. PubMed ID: 36263216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio on Predicting Responsiveness to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer Patients.
    Liu M; Feng Y; Zhang Y; Liu H
    Biomed Res Int; 2022; 2022():3839670. PubMed ID: 36212713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymph Node Regression to Neoadjuvant Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer: Prognostic Implication and a Predictive Model.
    Sun Y; Wu X; Lin H; Lu X; Huang Y; Chi P
    J Gastrointest Surg; 2021 Apr; 25(4):1019-1028. PubMed ID: 32219686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophil-to-Lymphocyte Ratio (NLR) as a Poor Predictive Biomarker for Pathological Response to Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer: A Prospective Study.
    Novin K; Fadavi P; Mortazavi N; Sanei M; Khoshbakht Ahmadi H; Barahman M; Noori R; Hoveidamanesh S; Shahin M; Taghizadeh-Hesary F
    Asian Pac J Cancer Prev; 2023 Jan; 24(1):61-67. PubMed ID: 36708552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictive and prognostic markers in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiation.
    Dudani S; Marginean H; Tang PA; Monzon JG; Raissouni S; Asmis TR; Goodwin RA; Gotfrit J; Cheung WY; Vickers MM
    BMC Cancer; 2019 Jul; 19(1):664. PubMed ID: 31277604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An inflammation index-based prediction of treatment response to neoadjuvant chemoradiotherapy for rectal mucinous adenocarcinoma.
    Sun Y; Huang Z; Chi P
    Int J Clin Oncol; 2020 Jul; 25(7):1299-1307. PubMed ID: 32274615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Role of Peripheral Neutrophil-Lymphocyte Ratio (NLR) and Platelet-Lymphocyte Ratio (PLR) in Patients with Rectal Cancer Undergoing Neoadjuvant Chemoradiotherapy.
    Ergen ŞA; Barlas C; Yıldırım C; Öksüz DÇ
    J Gastrointest Cancer; 2022 Mar; 53(1):151-160. PubMed ID: 33392960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A good preoperative immune prognostic index is precits a better prognosis for locally advanced rectal cancer patients with ypTNM stage II who underwent radical resection after neoadjuvant chemoradiotherapy.
    Li S; Wang Y; Cai H; Pan Z; Guan G
    Int J Colorectal Dis; 2023 Jul; 38(1):184. PubMed ID: 37395868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative Fibrinogen-Albumin Ratio Index (FARI) is a Reliable Prognosis and Chemoradiotherapy Sensitivity Predictor in Locally Advanced Rectal Cancer Patients Undergoing Radical Surgery Following Neoadjuvant Chemoradiotherapy.
    Lu S; Liu Z; Zhou X; Wang B; Li F; Ma Y; Wang W; Ma J; Wang Y; Wang H; Fu W
    Cancer Manag Res; 2020; 12():8555-8568. PubMed ID: 32982448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of pretreatment systemic inflammatory markers in patients with locally advanced rectal cancer following neoadjuvant chemoradiotherapy.
    Zhang Y; Liu X; Xu M; Chen K; Li S; Guan G
    Sci Rep; 2020 May; 10(1):8017. PubMed ID: 32415197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating lymphocytes as predictors of sensitivity to preoperative chemoradiotherapy in rectal cancer cases.
    Dou X; Wang RB; Yan HJ; Jiang SM; Meng XJ; Zhu KL; Xu XQ; Mu DB
    Asian Pac J Cancer Prev; 2013; 14(6):3881-5. PubMed ID: 23886201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does Neutrophil-to-Lymphocyte Ratio (NLR) Predict Pathologic Response to Neoadjuvant Chemoradiotherapy in Patients with Esophageal Squamous Cell Carcinoma?
    Anand S; Bhati G; Gurram R; Gnanasekaran S; Kate V; Pottakkat B; Kalayarasan R
    J Gastrointest Cancer; 2021 Jun; 52(2):659-665. PubMed ID: 32607960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic analysis of rectal cancer patients after neoadjuvant chemoradiotherapy: different prognostic factors in patients with different TRGs.
    Tang YL; Li DD; Duan JY; Wang X
    Int J Colorectal Dis; 2024 Jun; 39(1):93. PubMed ID: 38896374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Locally Advanced Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy.
    Shen J; Zhu Y; Wu W; Zhang L; Ju H; Fan Y; Zhu Y; Luo J; Liu P; Zhou N; Lu K; Zhang N; Li D; Liu L
    Med Sci Monit; 2017 Jan; 23():315-324. PubMed ID: 28100902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting the Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer Using Soluble Immune Checkpoints.
    Ari A; Sevik H; Sevinc MM; Tatar C; Buyukasik K; Surel AA; Idiz UO
    Cancer Biother Radiopharm; 2024 Apr; 39(3):247-254. PubMed ID: 38010745
    [No Abstract]   [Full Text] [Related]  

  • 19. Predicting Pathological Complete Regression with Haematological Markers During Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer.
    Lee JH; Song C; Kang SB; Lee HS; Lee KW; Kim JS
    Anticancer Res; 2018 Dec; 38(12):6905-6910. PubMed ID: 30504408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Predicting Complete Pathological Response in Rectal Cancer Patients Receiving Neoadjuvant Chemoradiotherapy.
    Karaca M; Salim E; Alemdar MS; Deniz Karaca Ö; Arıcı MÖ
    Med Sci Monit; 2024 Mar; 30():e943750. PubMed ID: 38544312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.